Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Stamenkovic

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Plos One|August 20, 2011
Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma developmentClaudio De Vito, Nicolo Riggi, Mario-Luca Suvà, et al.
Plos Medicine|December 21, 2006
Hyaluronate fragments reverse skin atrophy by a CD44-dependent mechanismGürkan Kaya, Christian Tran, Olivier Sorg, et al.
Cancer Research|December 17, 2005
Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cellsNicolò Riggi, Luisa Cironi, Paolo Provero, et al.
Scientific Reports|February 25, 2016
The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcomaLuisa Cironi, Tanja Petricevic, Victor Fernandes Vieira, et al.
Plos One|December 24, 2010
Synergistic effect of hyaluronate fragments in retinaldehyde-induced skin hyperplasia which is a Cd44-dependent phenomenonLaurent Barnes, Christian Tran, Olivier Sorg, et al.
Cell Reports|May 18, 2016
The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene SilencingNils Degrauwe, Tommy B Schlumpf, Michalina Janiszewska, et al.
Genes & Development|August 18, 2012
Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cellsMichalina Janiszewska, Mario L Suvà, Nicolo Riggi, et al.
Ebiomedicine|March 6, 2018
Reciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasisGiulia Fregni, Mathieu Quinodoz, Emely Möller, et al.
Cancer Research|April 3, 2008
EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cellsNicolò Riggi, Mario-Luca Suvà, Domizio Suvà, et al.
Cell Death & Disease|April 9, 2022
Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemiaOussama ElMokh, Saki Matsumoto, Paulina Biniecka, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Plos One|August 20, 2011
Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma developmentClaudio De Vito, Nicolo Riggi, Mario-Luca Suvà, et al.
Plos Medicine|December 21, 2006
Hyaluronate fragments reverse skin atrophy by a CD44-dependent mechanismGürkan Kaya, Christian Tran, Olivier Sorg, et al.
Cancer Research|December 17, 2005
Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cellsNicolò Riggi, Luisa Cironi, Paolo Provero, et al.
Scientific Reports|February 25, 2016
The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcomaLuisa Cironi, Tanja Petricevic, Victor Fernandes Vieira, et al.
Plos One|December 24, 2010
Synergistic effect of hyaluronate fragments in retinaldehyde-induced skin hyperplasia which is a Cd44-dependent phenomenonLaurent Barnes, Christian Tran, Olivier Sorg, et al.
Cell Reports|May 18, 2016
The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene SilencingNils Degrauwe, Tommy B Schlumpf, Michalina Janiszewska, et al.
Genes & Development|August 18, 2012
Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cellsMichalina Janiszewska, Mario L Suvà, Nicolo Riggi, et al.
Ebiomedicine|March 6, 2018
Reciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasisGiulia Fregni, Mathieu Quinodoz, Emely Möller, et al.
Cancer Research|April 3, 2008
EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cellsNicolò Riggi, Mario-Luca Suvà, Domizio Suvà, et al.
Cell Death & Disease|April 9, 2022
Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemiaOussama ElMokh, Saki Matsumoto, Paulina Biniecka, et al.
Pageof 7